You can look at the momentum for some stocks and have a feeling that it's about to end. Others, though, have such strong ...

Patrick R. O'Neil, Executive Vice President, Chief Legal Officer, and General Counsel at Ionis Pharmaceuticals Inc ...

The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Welcome to “Sector Spotlight,” where The Fly looks at a new industry every week and highlights its happenings. Stay Ahead of the ...

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Madrigal unveiled those figures Monday morning. The company said that its preliminary results indicated it earned $100 million to $103 million in the fourth quarter from Rezdiffra, its treatment for ...

For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...

The prolonged slump reflects subdued investor sentiment, as many have reduced their buying activity amid ongoing market uncertainty ...

Small- and mid-sized companies have consistently trailed large caps, but UBS believes that may change. Here are 40 top ...